| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |